Journal Francais D Ophtalmologie最新文献

筛选
英文 中文
Kératites bactériennes : rétrospective et prospective 2024 [细菌性角膜炎:回顾性和前瞻性 2024 年]。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-24 DOI: 10.1016/j.jfo.2024.104335
T. Bourcier , E. Koestel , C. Bertret , R. Yaïci , V. Borderie , N. Bouheraoua
{"title":"Kératites bactériennes : rétrospective et prospective 2024","authors":"T. Bourcier ,&nbsp;E. Koestel ,&nbsp;C. Bertret ,&nbsp;R. Yaïci ,&nbsp;V. Borderie ,&nbsp;N. Bouheraoua","doi":"10.1016/j.jfo.2024.104335","DOIUrl":"10.1016/j.jfo.2024.104335","url":null,"abstract":"<div><div>Une kératite bactérienne (KB) est une infection de la cornée causée par une ou plusieurs bactéries. Le port de lentilles de contact est le principal facteur de risque. <em>Staphylococcus</em> et <em>Pseudomonas</em> sont les agents pathogènes les plus fréquemment isolés dans les pays industrialisés. Les KB requièrent une prise en charge standardisée afin d’éviter tout retard diagnostique et thérapeutique susceptible d’assombrir le pronostic visuel. Sémiologie cornéenne, rapidité d’évolution des lésions, présence de facteurs de risque permettent au clinicien d’évoquer un diagnostic microbiologique mais seul le grattage cornéen permet, en isolant la (les) bactérie(s) en cause, de porter un diagnostic de certitude. La nature du traitement antibiotique dépend de la sévérité des lésions, du facteur de risque en cause et de la (des) bactérie(s) identifiée(s). Les corticoïdes ont montré leur efficacité en tant que traitement adjuvant et peuvent être utilisés dans certaines circonstances bien définies. Un traitement chirurgical est parfois nécessaire.</div></div><div><div>Bacterial keratitis (BK) is an infection of the cornea caused by one or more bacteria. Contact lens wear is the main risk factor. <em>Staphylococcus</em> and <em>Pseudomonas</em> are the most frequently isolated pathogens in developed countries. BK requires a standardized work-up to avoid diagnostic and therapeutic delays that may negatively affect visual prognosis. Corneal signs, the speed at which lesions progress and the presence of risk factors allow the clinician to presume an empirical microbiological diagnosis, but corneal scraping, which allows the isolation and identification of the bacteria involved in the infection, is the only way to confirm the diagnosis. The type of antibiotic treatment depends on the severity of the lesions, the risk factors involved, and the bacteria identified. Corticosteroids have been shown to be effective as adjuvant therapy and may be used under certain well-defined circumstances. Surgical treatment is sometimes necessary.</div></div>","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"47 10","pages":"Article 104335"},"PeriodicalIF":1.2,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conjonctivites virales et chlamydiennes [病毒和衣原体结膜炎]。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-24 DOI: 10.1016/j.jfo.2024.104337
A. Rousseau , S. Resnikoff , C. Vauloup-Fellous , M. Loukil , E. Barreau , S. Zina , M. Benali , M. Bouvet , M. Labetoulle
{"title":"Conjonctivites virales et chlamydiennes","authors":"A. Rousseau ,&nbsp;S. Resnikoff ,&nbsp;C. Vauloup-Fellous ,&nbsp;M. Loukil ,&nbsp;E. Barreau ,&nbsp;S. Zina ,&nbsp;M. Benali ,&nbsp;M. Bouvet ,&nbsp;M. Labetoulle","doi":"10.1016/j.jfo.2024.104337","DOIUrl":"10.1016/j.jfo.2024.104337","url":null,"abstract":"<div><div>Les conjonctivites virales sont les conjonctivites les plus fréquentes. Elles ont en commun leur potentiel de transmission et sont très largement dominées en fréquence par les conjonctivites et kératoconjonctivites liées aux adénovirus (ADV). Ces dernières constituent les infections de la surface oculaire les plus fréquentes et peuvent être à l’origine de fibrose conjonctivale et d’opacités cornéennes. Les autres conjonctivites virales sont le plus souvent satellites d’une infection systémique et ont, en général, une évolution spontanément favorable. Les conjonctivites chlamydiennes sont quant à elles dominées par le trachome, qui sévit encore dans 42 pays et reste la première cause de cécité infectieuse dans le monde. Dans les pays industrialisés, les Chlamydia sont responsables de conjonctivites néonatales et de conjonctivites parfois chroniques, pouvant être associées à des maladies sexuellement transmissibles. Cette revue synthétique fournit aux cliniciens l’essentiel des données microbiologiques, épidémiologiques, cliniques et thérapeutiques de ces deux grands groupes de conjonctivites infectieuses.</div></div><div><div>Viral conjunctivitis is the most common type of conjunctivitis. It is contagious and is predominantly seen as adenovirus-related conjunctivitis and keratoconjunctivitis (ADV). These infections are the most frequent ocular surface infections and can lead to conjunctival scarring and corneal opacities. Other types of viral conjunctivitis are often secondary to systemic infection and typically resolve spontaneously. Chlamydial conjunctivitis, on the other hand, is dominated by trachoma, which remains endemic in 42 countries and is still the leading cause of infectious blindness worldwide. In industrialized countries, chlamydia can also cause neonatal conjunctivitis and sometimes chronic conjunctivitis, occasionally associated with sexually transmitted diseases. This comprehensive review provides clinicians with essential microbiological, epidemiological, clinical, and therapeutic data on these two major groups of infectious conjunctivitis.</div></div>","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"47 10","pages":"Article 104337"},"PeriodicalIF":1.2,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocole national de diagnostic et de soin pour la prise en charge de la rétinopathie du prématuré : résumé pour le médecin traitant et le généraliste [早产儿视网膜病变诊断和护理国家方案:主治医生摘要]。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-24 DOI: 10.1016/j.jfo.2024.104333
A. Daruich , D. Bremond-Gignac , A. Aziz , A. Barjol , M. Beylerian , R. Blanco , P. Cairet , G. Caputo , T. Chapron , E. Kermorvant , G. Le Meur , C. Nicaise , PNDS ROP GROUP
{"title":"Protocole national de diagnostic et de soin pour la prise en charge de la rétinopathie du prématuré : résumé pour le médecin traitant et le généraliste","authors":"A. Daruich ,&nbsp;D. Bremond-Gignac ,&nbsp;A. Aziz ,&nbsp;A. Barjol ,&nbsp;M. Beylerian ,&nbsp;R. Blanco ,&nbsp;P. Cairet ,&nbsp;G. Caputo ,&nbsp;T. Chapron ,&nbsp;E. Kermorvant ,&nbsp;G. Le Meur ,&nbsp;C. Nicaise ,&nbsp;PNDS ROP GROUP","doi":"10.1016/j.jfo.2024.104333","DOIUrl":"10.1016/j.jfo.2024.104333","url":null,"abstract":"&lt;div&gt;&lt;div&gt;La rétinopathie du prématuré (ROP, ORPHA : 90050), responsable de la majorité des séquelles visuelles des anciens prématurés, est la principale cause évitable de cécité infantile dans les pays à revenu élevé et intermédiaire. Elle reste cependant une maladie rare dans ses formes sévères. Bien que les recommandations relatives au dépistage de la maladie soient bien établies en France, la prise en charge en cas de ROP nécessitant un traitement est moins codifiée, d’autant plus que l’arsenal thérapeutique inclut l’utilisation des médicaments ayant récemment obtenu une autorisation de mise sur le marché (AMM). Cette prise en charge complexe requiert le concours multidisciplinaire d’ophtalmo-pédiatres, de chirurgiens vitréo-rétiniens, des néonatologistes, d’anesthésistes pédiatriques, d’infirmières et d’orthoptistes, au sein d’une structure adaptée au nouveau-né prématuré. Il existe un réel besoin d’unifier les pratiques nationales autour de cette pathologie, avec une demande forte des différents acteurs de cette prise en charge. L’objectif de ce Protocole national de diagnostic et de soins (PNDS) est de présenter aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale actuelle et le parcours de soins des prématurés nécessitant un traitement pour une ROP. Il a pour but d’optimiser et d’harmoniser la prise en charge de cette maladie sur l’ensemble du territoire. Les principales indications au traitement, les différentes modalités de traitement incluant la photocoagulation laser, les injections d’anti-VEGF et la chirurgie vitréo-rétinienne, sont revues afin d’établir des recommandations de bonne pratique pour leur réalisation et pour le suivi post-traitement.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;Retinopathy of prematurity (ROP, ORPHA: 90050) is the main cause of visual impairment in preterm infants and the leading preventable cause of childhood blindness in high- and middle-income countries. However, severe stages of the disease remain rare. While screening recommendations for the disease are well-established in France, management of ROP requiring treatment is less standardized, especially since new therapeutic options have been approval on this indication. The management of preterm infants requiring treatment for ROP is complex and involves a multidisciplinary team, including pediatric ophthalmologists, vitreoretinal surgeons, neonatologists, pediatric anesthetists, nurses, and orthoptists, within an adapted structure for premature infants care. There is a genuine need to unify national practices, with a strong demand from physicians involved in ROP care along the country. The objective of this National Diagnostic and Care Protocol (PNDS) is to provide guidelines for diagnostic and management for ROP, and to optimize and harmonize the management of this disease across the country. The main treatment indications, the different treatment modalities including laser photocoagulation, anti-VEGF injections, and vitreoretinal surgery ","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104333"},"PeriodicalIF":1.2,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bilateral colobomatous microphthalmia with unilateral orbital cyst]. [双侧疣状小眼伴单侧眼眶囊肿]。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-17 DOI: 10.1016/j.jfo.2024.104320
J Jacquemart, L Hamoudi, A Mekerke
{"title":"[Bilateral colobomatous microphthalmia with unilateral orbital cyst].","authors":"J Jacquemart, L Hamoudi, A Mekerke","doi":"10.1016/j.jfo.2024.104320","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104320","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104320"},"PeriodicalIF":1.2,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of phacoemulsification with iStent inject® implantation in narrow angle glaucoma 在窄角型青光眼中植入 iStent inject® 进行超声乳化术的长期疗效。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-11 DOI: 10.1016/j.jfo.2024.104298
Z. Cheng, T. Berman, A. Choudhary
{"title":"Long-term outcomes of phacoemulsification with iStent inject® implantation in narrow angle glaucoma","authors":"Z. Cheng,&nbsp;T. Berman,&nbsp;A. Choudhary","doi":"10.1016/j.jfo.2024.104298","DOIUrl":"10.1016/j.jfo.2024.104298","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To assess the outcomes of phacoemulsification with iStent inject implantation (phaco-iStent) in patients with narrow angle glaucoma (NAG) at a single tertiary eye centre.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Retrospective clinical cohort study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Patients undergoing phaco-iStent for NAG between March 2018 and October 2020 under the glaucoma team at a tertiary referral hospital were included. Data was analysed from a surgical outcome database. Primary outcomes included postoperative change in the mean intraocular pressure (IOP) and medications. Success was defined at two IOP cut-off points:&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;21&lt;!--&gt; &lt;!--&gt;mmHg and&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;15&lt;!--&gt; &lt;!--&gt;mmHg with (qualified) or without (complete) drops. Failure was repeat glaucoma surgery or loss of light perception (LP).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Fifty-seven eyes with a mean follow-up of 32&lt;!--&gt; &lt;!--&gt;months (range 12&lt;!--&gt; &lt;!--&gt;months to 36&lt;!--&gt; &lt;!--&gt;months) were included. Mean IOP changed from 19.7&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;4.2&lt;!--&gt; &lt;!--&gt;mmHg (range 12–28) to 14.0, 14.9 and 14.6 at 12, 24 and 36&lt;!--&gt; &lt;!--&gt;months. Drops reduced from 2.2&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.7 to 0.92&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;1.24 at the last follow-up. Complete success for an IOP&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;21&lt;!--&gt; &lt;!--&gt;mmHg was 49%, 39%, 37% and qualified success was 96%, 92% and 95% at 12, 24 and 36&lt;!--&gt; &lt;!--&gt;months. An IOP&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;15&lt;!--&gt; &lt;!--&gt;mmHg (qualified) was achieved in 74%, 58%, 54% at 6, 12, 24 and 36&lt;!--&gt; &lt;!--&gt;months. Three patients (5%) required further glaucoma surgery, one patient underwent selective laser trabeculoplasty and one patient requiring peri-ocular steroid treatment due to persistent cystoid macular oedema. There were no other long-term complications.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Phacoemulsification with iStent inject is a safe and effective surgical option in the management of narrow angle glaucoma.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Évaluer les résultats de la phacoémulsification avec implantation d’iStent inject (phaco-iStent) chez les patients atteints de glaucome à angle étroit (GAE) dans un centre ophtalmologique tertiaire unique.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conception&lt;/h3&gt;&lt;div&gt;Étude de cohorte clinique rétrospective.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Les patients subissant une phaco-iStent pour un GAE entre mars 2018 et octobre 2020 sous l’équipe de glaucome d’un hôpital de référence tertiaire ont été inclus. Les données ont été analysées à partir d’une base de données de résultats chirurgicaux. Les critères principaux comprenaient la variation postopératoire de la pression intraoculaire moyenne (PIO) et des médicaments. La réussite a été définie à deux seuils de PIO :&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;21&lt;!--&gt; &lt;!--&gt;mmHg et&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;15&lt;!--&gt; &lt;!--&gt;mmHg avec (qualifiée) ou sans (complète) chutes. L’échec était défini comme une chirurgie du glaucome répétée ou une perte de la perception lumineuse (PL).&lt;/","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104298"},"PeriodicalIF":1.2,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute unilateral conjunctivitis as first manifestation of monkeypox viral infection after the 2023 vaccination campaign. 急性单侧结膜炎是 2023 年疫苗接种活动后猴痘病毒感染的首发症状。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-10 DOI: 10.1016/j.jfo.2024.104318
A Saladrigas, N Sabater-Cruz, M A Gil, V Lázaro-Rodríguez, M Caminal-Caramés, S Conversa, Z Del Campo
{"title":"Acute unilateral conjunctivitis as first manifestation of monkeypox viral infection after the 2023 vaccination campaign.","authors":"A Saladrigas, N Sabater-Cruz, M A Gil, V Lázaro-Rodríguez, M Caminal-Caramés, S Conversa, Z Del Campo","doi":"10.1016/j.jfo.2024.104318","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104318","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104318"},"PeriodicalIF":1.2,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A rare conjunctival nevus: Spitz nevus]. [一种罕见的结膜痣:Spitz 痣]。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-09 DOI: 10.1016/j.jfo.2024.104316
R Benkirane, R-El Hachimi, L Sbai, T Boutaj, Z Hilali, H El Ouazzani, N Cherradi, S Tachfouti, A Amazouzi, O Cherkaoui
{"title":"[A rare conjunctival nevus: Spitz nevus].","authors":"R Benkirane, R-El Hachimi, L Sbai, T Boutaj, Z Hilali, H El Ouazzani, N Cherradi, S Tachfouti, A Amazouzi, O Cherkaoui","doi":"10.1016/j.jfo.2024.104316","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104316","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104316"},"PeriodicalIF":1.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Third nerve schwannoma mimicking recurrent painful ophthalmoplegic neuropathy. 模仿复发性痛性眼球神经病的第三神经分裂瘤。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-08 DOI: 10.1016/j.jfo.2024.104319
K Mairot, N Stolowy, A El Ahmadi, T David, D Denis
{"title":"Third nerve schwannoma mimicking recurrent painful ophthalmoplegic neuropathy.","authors":"K Mairot, N Stolowy, A El Ahmadi, T David, D Denis","doi":"10.1016/j.jfo.2024.104319","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104319","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104319"},"PeriodicalIF":1.2,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term clinical and confocal microscopy changes after synthetic endothelial replacement. 合成内皮替换后的短期临床和共聚焦显微镜变化。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-07 DOI: 10.1016/j.jfo.2024.104302
L Fernández-Vega-Cueto, C Lisa, R Alvarado-Villacorta
{"title":"Short-term clinical and confocal microscopy changes after synthetic endothelial replacement.","authors":"L Fernández-Vega-Cueto, C Lisa, R Alvarado-Villacorta","doi":"10.1016/j.jfo.2024.104302","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104302","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104302"},"PeriodicalIF":1.2,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Slit-lamp images of bilateral secondary corneal amyloidosis. 双侧继发性角膜淀粉样变性的裂隙灯图像。
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2024-10-07 DOI: 10.1016/j.jfo.2024.104312
J-H Luo, Q Hu
{"title":"Slit-lamp images of bilateral secondary corneal amyloidosis.","authors":"J-H Luo, Q Hu","doi":"10.1016/j.jfo.2024.104312","DOIUrl":"https://doi.org/10.1016/j.jfo.2024.104312","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":"104312"},"PeriodicalIF":1.2,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信